The Alliance for Regenerative Medicine: Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan
ATMPs are uniquely positioned to attack cancer at its source, bringing life-changing benefits to patients
BRUSSELS, BELGIUM - February 3, 2021
The Alliance for Regenerative Medicine (ARM) the global voice of the regenerative medicine and advanced therapies sector applauds the EU Beating Cancer Plan s identification of Advanced Therapy Medicinal Products (ATMPs) as part of a comprehensive cancer solution. ATMPs include cell and gene therapies that have already revolutionized the treatment of some aggressive forms of blood cancers and hold great promise for addressing other types of cancer.
February 1, 2021
For the third consecutive year, following the publication of Gibson Dunn’s ninth annual U.S. Cybersecurity and Data Privacy Outlook and Review on Data Privacy Day, we offer this separate International Outlook and Review.
Like many recent years, 2020 saw significant developments in the evolution of the data protection and cybersecurity landscape in the European Union (“
EU”):
CJEU” or “
Court”) struck down as legally invalid the EU-U.S. Privacy Shield, on which some companies relied to transfer personal data from the EU to the U.S. While companies are turning to other frameworks to transfer personal data, such as Standard Contract Clauses (“
Friday, January 22, 2021
Australia
Certain NICNAS Exemption Provisions Available Until August 31, 2022: Australia announced on December 17, 2020, that under the transitional arrangements, some exemption provisions that existed under the previous law, the Industrial Chemicals (Notification and Assessment) Act 1989, will be available to introducers until
August 31, 2022. Introductions made under this arrangement are taken to be Australian Industrial Chemicals Introduction Scheme (AICIS) “reported introductions” under Section 27 of the Industrial Chemicals Act 2019 (current law). Australia states that this means that if the introduction meets the criteria for one of the exemption provisions that existed under the National Industrial Chemicals Notification and Assessment Scheme (NICNAS), companies are authorized to introduce the chemical under AICIS as a “reported introduction” until